These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8623456)

  • 1. Cost-containment strategies in transplantation: the utility of cyclosporine-ketoconazole combination therapy.
    Odocha O; Kelly B; Trimble S; Murigande C; Toussaint RM; Callender CO
    Transplant Proc; 1996 Apr; 28(2):907-9. PubMed ID: 8623456
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacoeconomics of Neoral, a new formulation of cyclosporine, in renal transplantation.
    Abella I
    Transplant Proc; 1996 Dec; 28(6):3131-4. PubMed ID: 8962213
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and safety of low-dose ketoconazole (50 mg) to reduce the cost of cyclosporine in renal allograft recipients.
    Abraham MA; Thomas PP; John GT; Job V; Shankar V; Jacob CK
    Transplant Proc; 2003 Feb; 35(1):215-6. PubMed ID: 12591369
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporine pharmacokinetic profiles in stable renal allograft recipients converting from Sandimmun to Neoral.
    Vathsala A; Lee WT; Jacob E; Woo KT
    Transplant Proc; 1996 Jun; 28(3):1324-6. PubMed ID: 8658678
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of Markov modeling for evaluating the cost-effectiveness of immunosuppressive therapies in renal transplant recipients.
    Lewis RL; Canafax DM; Pettit KG; DiCesare J; Kaniecki DJ; Arnold RJ; Roberts MS
    Transplant Proc; 1996 Aug; 28(4):2214-7. PubMed ID: 8769203
    [No Abstract]   [Full Text] [Related]  

  • 6. Economic relevance of cyclosporine microemulsion in kidney transplanted patients.
    Cogny-Van Weydevelt F; Ngohou C; Bacquaert-Dufour K; Touzard D; Kerkeni N; Maksour E; Riberi P
    Transplant Proc; 1998 Sep; 30(6):2802-3. PubMed ID: 9745571
    [No Abstract]   [Full Text] [Related]  

  • 7. Maintenance immunosuppression using cyclosporine monotherapy in adult orthotopic liver transplant recipients.
    Tchervenkov JI; Tector AJ; Cantarovich M; Tahta SA; Asfar A; Naimi J; Elias N; Barkun J
    Transplant Proc; 1996 Aug; 28(4):2247-9. PubMed ID: 8769214
    [No Abstract]   [Full Text] [Related]  

  • 8. Case study: conversion of a liver transplant patient from cyclosporine Sandimmune to Neoral.
    Levy GA
    Transplant Proc; 1996 Aug; 28(4):2252-3. PubMed ID: 8769216
    [No Abstract]   [Full Text] [Related]  

  • 9. Case reports on conversion to Neoral therapy in renal transplant patients.
    Curtis JJ
    Transplant Proc; 1996 Aug; 28(4):2221-2; discussion 2218. PubMed ID: 8769205
    [No Abstract]   [Full Text] [Related]  

  • 10. Ketoconazole in posttransplant triple therapy: comparison of costs and outcomes.
    Gueco IP; Tan-Torres T; Baniga U; Alano F
    Transplant Proc; 1992 Oct; 24(5):1709-14. PubMed ID: 1412805
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety and efficacy of long-term cyclosporine-ketoconazole administration and preliminary results of a randomized trial.
    First MR; Schroeder TJ; Michael A; Hariharan S; Weiskittel P; Alexander JW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):591-4. PubMed ID: 8438428
    [No Abstract]   [Full Text] [Related]  

  • 12. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.
    Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO
    Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of nicardipine on blood cyclosporine levels in renal transplant patients.
    Guan D; Wang R; Lu J; Wang M; Xu C
    Transplant Proc; 1996 Jun; 28(3):1311-2. PubMed ID: 8658673
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of cyclosporine dosing on creatinine levels in hepatic transplant recipients.
    Gross CR; Savik SK; Ascher NL; Gordon RD; Klintmalm GB; Payne W; Shaw BW; Strasburg K; Parker A; Wiesner RH
    Transplant Proc; 1994 Oct; 26(5):2686-90. PubMed ID: 7940841
    [No Abstract]   [Full Text] [Related]  

  • 15. Conversion from cyclosporine to Neoral in pediatric recipients for kidney, liver, and heart transplantation.
    Holmberg C; Laine J; Jalanko H; Leijala M; Hoppu K
    Transplant Proc; 1996 Aug; 28(4):2262-3. PubMed ID: 8769219
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of tolerability, safety, and efficacy of cyclosporine microemulsion in renal transplant recipients.
    Gracida C; Melchor JL; Miranda ME; Bartolano C
    Transplant Proc; 1996 Aug; 28(4):2171-3. PubMed ID: 8769191
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperamylasemia in kidney transplant recipients.
    Yokoyama I; Hayashi S; Kobayashi T; Negita M; Katayama A; Nagasaka R; Namii Y; Kojima T; Koike C; Uchida K; Takagi H
    Transplant Proc; 1996 Jun; 28(3):1476-7. PubMed ID: 8658748
    [No Abstract]   [Full Text] [Related]  

  • 18. Conversion from Sandimmune to Neoral in stable liver graft recipients.
    Pollard SG; Lodge JP
    Transplant Proc; 1996 Aug; 28(4):2244-6. PubMed ID: 8769213
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined liver-kidney transplantation: our experience.
    Torregrosa JV; Iñigo P; Navasa M; Rimola A; Grande L; Oppenheimer F
    Transplant Proc; 1999 Sep; 31(6):2308. PubMed ID: 10500591
    [No Abstract]   [Full Text] [Related]  

  • 20. Application of corbrin capsule in human renal transplantation.
    Min Z; Oi J; Zhu Y; Wei W
    Transplant Proc; 1996 Jun; 28(3):1626-8. PubMed ID: 8658813
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.